1. Home
  2. CMND vs SSY Comparison

CMND vs SSY Comparison

Compare CMND & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • SSY
  • Stock Information
  • Founded
  • CMND 2017
  • SSY 1959
  • Country
  • CMND Canada
  • SSY United States
  • Employees
  • CMND N/A
  • SSY N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • SSY Hospital/Nursing Management
  • Sector
  • CMND Health Care
  • SSY Health Care
  • Exchange
  • CMND Nasdaq
  • SSY Nasdaq
  • Market Cap
  • CMND 5.3M
  • SSY 5.3M
  • IPO Year
  • CMND N/A
  • SSY N/A
  • Fundamental
  • Price
  • CMND $1.25
  • SSY $0.76
  • Analyst Decision
  • CMND
  • SSY
  • Analyst Count
  • CMND 0
  • SSY 0
  • Target Price
  • CMND N/A
  • SSY N/A
  • AVG Volume (30 Days)
  • CMND 65.9K
  • SSY 17.6K
  • Earning Date
  • CMND 02-05-2025
  • SSY 02-11-2025
  • Dividend Yield
  • CMND N/A
  • SSY N/A
  • EPS Growth
  • CMND N/A
  • SSY N/A
  • EPS
  • CMND N/A
  • SSY N/A
  • Revenue
  • CMND N/A
  • SSY $31,808,000.00
  • Revenue This Year
  • CMND N/A
  • SSY N/A
  • Revenue Next Year
  • CMND N/A
  • SSY N/A
  • P/E Ratio
  • CMND N/A
  • SSY N/A
  • Revenue Growth
  • CMND N/A
  • SSY N/A
  • 52 Week Low
  • CMND $0.92
  • SSY $0.53
  • 52 Week High
  • CMND $3.58
  • SSY $0.98
  • Technical
  • Relative Strength Index (RSI)
  • CMND 43.14
  • SSY 47.08
  • Support Level
  • CMND $1.26
  • SSY $0.74
  • Resistance Level
  • CMND $1.53
  • SSY $0.88
  • Average True Range (ATR)
  • CMND 0.09
  • SSY 0.04
  • MACD
  • CMND -0.00
  • SSY -0.00
  • Stochastic Oscillator
  • CMND 6.07
  • SSY 21.36

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About SSY SunLink Health Systems Inc.

SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.

Share on Social Networks: